Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology. | Aging (Albany NY) | 2023 | 37870753 | PubTator, text mining | PubMed |
| Different seminal ejaculated fractions in artificial insemination condition the protein cargo of oviductal and uterine extracellular vesicles in pig. | Front Cell Dev Biol | 2023 | 37868907 | PubTator, text mining | PubMed |
| Large-Scale Identification of Lysine Crotonylation Reveals Its Potential Role in Oral Squamous Cell Carcinoma. | Cancer Manag Res | 2023 | 37868687 | PubTator, text mining | PubMed |
| Pharmacophore Model-Based Virtual Screening Workflow for Discovery of Inhibitors Targeting Plasmodium falciparum Hsp90. | ACS Omega | 2023 | 37867657 | PubTator, text mining | PubMed |
| Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis. | Clin Immunol | 2023 | 37866785 | PubTator, text mining | PubMed |
| High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. | Cell Rep Med | 2023 | 37858338 | PubTator, text mining | PubMed |
| Vitamin D status associates with skeletal muscle loss after anterior cruciate ligament reconstruction. | JCI Insight | 2023 | 37856482 | PubTator, text mining | PubMed |
| HSP90 expression is associated with outcome in pulmonary carcinoid tumor patients. | Transl Lung Cancer Res | 2023 | 37854156 | PubTator, text mining | PubMed |
| Heat shock protein 90 (Hsp90) inhibitor STA-9090 (Ganetespib) ameliorates inflammation in a mouse model of atopic dermatitis. | Cell Stress Chaperones | 2023 | 37851180 | PubTator, text mining | PubMed |
| Proteomics reveals time-dependent protein corona changes in the intracellular pathway. | Acta Biomater | 2023 | 37839632 | PubTator, text mining | PubMed |
| Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer. | Int Immunopharmacol | 2023 | 37839277 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Triple-Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential. | Cancers (Basel) | 2023 | 37835573 | PubTator, text mining | PubMed |
| Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells. | Int J Mol Sci | 2023 | 37834227 | PubTator, text mining | PubMed |
| MiR-148a-3p within HucMSC-Derived Extracellular Vesicles Suppresses Hsp90b1 to Prevent Fibroblast Collagen Synthesis and Secretion in Silica-Induced Pulmonary Fibrosis. | Int J Mol Sci | 2023 | 37833927 | PubTator, text mining | PubMed |
| Quantitative analysis of acetylation in peste des petits ruminants virus-infected Vero cells. | Virol J | 2023 | 37817180 | PubTator, text mining | PubMed |
| Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation. | Sci Rep | 2023 | 37816854 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndrome. | iScience | 2023 | 37810210 | PubTator, text mining | PubMed |
| Modular characteristics and mechanism of action of herbs for type 2 diabetes treatment in Chinese medicine. | Heliyon | 2023 | 37809579 | PubTator, text mining | PubMed |
| Identification of hub genes and potential inhibitory compounds in the process of liver transplantation through transcriptome sequencing. | Mol Cell Probes | 2023 | 37802426 | PubTator, text mining | PubMed |
| The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. | Front Endocrinol (Lausanne) | 2023 | 37795365 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=20